Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0320 DKK
−24.61 M DKK
0.00 DKK
898.35 M
About PHARMA EQUITY GROUP A/S
Sector
Industry
CEO
Thomas Kaas Selso
Website
Headquarters
Hørsholm
Founded
2002
ISIN
DK0061155009
FIGI
BBG000PRFV16
Pharma Equity Group A/S is a property company, which engages in the investment of real estate. The firm invests directly or indirectly through companies or agreement-based rights using equity or financing. It manages investments in bonds, shares, securities, and other assets. The company was founded on September 20, 2002 and is headquartered in Hørsholm, Denmark.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PEG is 0.1575 DKK — it has decreased by −2.18% in the past 24 hours. Watch PHARMA EQUITY GROUP A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange PHARMA EQUITY GROUP A/S stocks are traded under the ticker PEG.
PEG stock has fallen by −3.09% compared to the previous week, the month change is a −25.24% fall, over the last year PHARMA EQUITY GROUP A/S has showed a −67.19% decrease.
PEG stock is 3.53% volatile and has beta coefficient of 0.26. Track PHARMA EQUITY GROUP A/S stock price on the chart and check out the list of the most volatile stocks — is PHARMA EQUITY GROUP A/S there?
Today PHARMA EQUITY GROUP A/S has the market capitalization of 192.72 M, it has decreased by −12.78% over the last week.
Yes, you can track PHARMA EQUITY GROUP A/S financials in yearly and quarterly reports right on TradingView.
PHARMA EQUITY GROUP A/S is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
PEG earnings for the last quarter are −0.01 DKK per share, whereas the estimation was −0.01 DKK resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.00 DKK per share. See more details about PHARMA EQUITY GROUP A/S earnings.
PHARMA EQUITY GROUP A/S revenue for the last quarter amounts to 0.00 DKK, matching the estimated figure, and no changes in revenue are expected for the next quarter.
PEG net income for the last quarter is −6.75 M DKK, while the quarter before that showed −5.86 M DKK of net income which accounts for −15.10% change. Track more PHARMA EQUITY GROUP A/S financial stats to get the full picture.
No, PEG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PEG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMA EQUITY GROUP A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMA EQUITY GROUP A/S technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMA EQUITY GROUP A/S stock shows the strong sell signal. See more of PHARMA EQUITY GROUP A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.